Irbesartan

Product NDC
68382-301
11-digit product format
683820301
Labeler code
68382
Product ID
68382-301_3d8cb010-c629-4de6-9bb1-caaa7463e37c
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Irbesartan
Dosage form
TABLET
Route
ORAL
Labeler
Zydus Pharmaceuticals USA Inc.
Application
ANDA079213
Marketing category
ANDA
Marketing start
2017-12-08
Marketing end
0000-00-00
Substance
IRBESARTAN
Active strength
300 mg/1
Pharmacologic classes
Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
68382-301-0568382030105500 TABLET in 1 BOTTLE (68382-301-05) 500 tablet2017-12-080000-00-00NoNoCurrent
68382-301-066838203010630 TABLET in 1 BOTTLE (68382-301-06) 30 tablet2017-12-080000-00-00NoNoCurrent
68382-301-10683820301101000 TABLET in 1 BOTTLE (68382-301-10) 1000 tablet2017-12-080000-00-00NoNoCurrent
68382-301-166838203011690 TABLET in 1 BOTTLE (68382-301-16) 90 tablet2017-12-080000-00-00NoNoCurrent
68382-301-776838203017710 BLISTER PACK in 1 CARTON (68382-301-77) > 10 TABLET in 1 BLISTER PACK (68382-301-30) 10 blister pack2017-12-080000-00-00NoNoCurrent